Baird Medical Investment Holdings Limited (BDMD) NASDAQ
1.75
-0.01(-0.57%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.75
-0.01(-0.57%)
Currency In USD
Sector
Healthcare
Industry
Medical - Devices
Employees
148
First IPO Date
December 16, 2021
| Name | Title | Pay | Year Born |
| Haimei Wu | Chairwoman of the Board of Directors & Chief Executive Officer | 55,422 | 1982 |
| Mark S. Saxton | Chief Executive Officer U.S. Subsidiary | 0 | 1965 |
| Wei Hou | Executive Director | 42,239 | 1970 |
| Quan Qiu | Chief Administrative Officer & Executive Director | 49,468 | 1993 |
| Rongjian Lu | Chief Technology Officer & Deputy GM | 0 | 1967 |
| Jie Li | Acting Chief Financial Officer | 0 | 1988 |
Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.